A late-stage medication development company specific in oncology and endocrine therapy.

Perifosine is also in Stage 3 trials in multiple myeloma and colorectal tumor currently, as well as in Stage 2 trials for multiple types of cancer.. Aeterna Zentaris presents data of perifosine Phase 1 trial for recurrent pediatric solid tumors at ASCO Perifosine demonstrated to be safe and tolerable, with early signals of clinical advantage in advanced refractory pediatric neuroblastoma patients Aeterna Zentaris Inc. , a late-stage medication development company specific in oncology and endocrine therapy, today announced that Phase 1 data of perifosine in recurrent pediatric solid tumors was offered yesterday in the pediatric solid tumor poster debate program held at the 46th Annual Interacting with of the American Culture of Clinical Oncology taking place in Chicago.The ability to measure the electrical activity in the brain by means of electrodes on the head is a handy tool to review brain functions since it is noninvasive and easy to use. The interpretation of the EEG indicators remains, however, difficult. The main reason for this is that the exact relationship between your activity produced in the brain compared to that measured on the scalp is certainly unclear. Therefore, a question of paramount useful importance is certainly how EEG may be used to deduce neural activity in the mind. Lately, Kevin Whittingstall and Nikos Logothetis from the Max Planck Institute for Biological Cybernetics in Tubingen possess addressed this very question for the very first time. Related StoriesAdvances entirely mount human brain imaging: an interview with Patrick Myles, President, Huron Digital PathologyBrain health: how will you decrease cognitive decline? An interview with Heather Snyder, Ph.D.Liposomal sizing and the Coulter principle: an interview with Professor Melvin E.